GET DAILY SIGNALSCTS Corporation (CTS) Delivers Record Q3 Margins and Raises Full-Year Guidance
Key Takeaways
- CTS Corporation reported third-quarter 2026 sales of $149.6 million, up 5% year over year and above consensus estimates of roughly $145.9 million.
- Adjusted diluted earnings per share (EPS) reached a record $0.77, up from $0.60 a year earlier and well ahead of the consensus estimate of approximately $0.65.
- Adjusted gross margin climbed to a record 42.2%, up 330 basis points versus the prior-year quarter, while adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) margin rose to 24.7%.
- Management raised full-year 2026 guidance to sales of $580 million to $590 million and adjusted diluted EPS of $2.78 to $2.88.
- The recently completed acquisition of Millar advances the company's diversification strategy, particularly in the medical end market.
- For more detail on CTS, explore Major News, Today's Price Move, Price Targets, and Forecast on Tickeron's dedicated pages.
- Discover related opportunities by exploring Trending AI Robots.
Why These Results Matter for the Investment Case
CTS Corporation, a designer and manufacturer of electronic components and sensors serving original equipment manufacturers (OEMs), has been steadily shifting its revenue mix toward faster-growing diversified end markets. The third quarter of 2026 offered investors a fresh read on that strategy, as medical, aerospace and defense, and industrial segments increasingly complement the company's traditional transportation business. With transportation tied to softer global light-vehicle production, execution in diversified markets and margin discipline have become central to the investment thesis. This report also carried added weight because it followed the announcement of the Millar acquisition, a deal that expands CTS's presence in medical sensing and reshapes its long-term growth profile.
Breaking Down the Reported Numbers
For the third quarter ended September 30, 2026, CTS posted sales of $149.6 million, a 5% increase from $143.0 million in the prior-year period and about 2.5% above consensus estimates near $145.9 million. Diversified end-market sales rose 7% year over year and represented 60% of total revenue, while transportation sales grew 2%.
Net earnings were $17.8 million, up from $13.7 million a year earlier, with GAAP diluted EPS of $0.61 versus $0.46 in the year-ago quarter. On an adjusted basis, which excludes non-recurring items, diluted EPS reached a record $0.77, up from $0.60 and comfortably above the consensus of roughly $0.65.
Profitability improved meaningfully. Adjusted gross margin hit a record 42.2%, up 330 basis points year over year, and adjusted EBITDA margin expanded about 90 basis points to 24.7%. Operating cash flow reached $44 million in the quarter, supporting a strong balance sheet. Management also raised full-year 2026 guidance, now expecting sales of $580 million to $590 million and adjusted diluted EPS of $2.78 to $2.88.
I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
How the Market Responded
Shares of CTS jumped in morning trading on October 27, 2026, following the release, with reports indicating a rise of roughly 4.5% as investors responded to results that topped estimates and an upwardly revised full-year outlook. The stock had already gained about 25.8% year to date, outpacing the broader S&P 500, reflecting improving sentiment around the company's diversification progress and margin expansion.
Investor interpretation centered on the durability of growth in diversified end markets and the record profitability. The beat on both revenue and adjusted EPS, combined with raised guidance, signaled stronger-than-expected operational execution. At the same time, attention remained on the more modest transportation growth and management's caution around tariffs, geopolitical uncertainty, and a normalization of profitability in coming quarters.
What to Watch Going Forward
Looking ahead, CTS's raised full-year guidance implies continued momentum into the fourth quarter, supported by a healthy order backlog in aerospace and defense and resilient demand in industrial and medical markets. The company's book-to-bill ratio of 1.18 for the third quarter, with a notably strong 1.9 reading in aerospace and defense, suggests sustained customer demand heading into 2027.
The Millar acquisition will be a central watch item. Expected to contribute roughly $30 million in annual revenue and to become accretive to earnings in the second half of 2027, the deal deepens CTS's exposure to medical and industrial sensing. Investors will monitor integration progress and whether the transaction delivers the anticipated margin and diversification benefits.
Key risk factors include tariff changes, metals and oil inflation, and potential softness in global light-vehicle production. Management has also flagged that record profitability may normalize in the near term as favorable end-market mix and foreign-exchange benefits ease. How CTS sustains margins while absorbing Millar and navigating cost pressures will likely shape sentiment in the quarters ahead.
Exploring AI-Powered Research Tools
In my own analysis, I turned to Tickeron’s AI Screener to quickly compare CTS against peers on fundamentals and technical signals. It helped surface a few similar names worth watching alongside this one. The platform lets users filter by industry, patterns, and performance metrics, which can streamline the process of identifying opportunities in a sector like electronic components.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
CTS sees its Stochastic Oscillator recovers from oversold territory
On October 27, 2026, the Stochastic Oscillator for CTS moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 59 instances where the indicator left the oversold zone. In 44 of the 59 cases the stock moved higher in the following days. This puts the odds of a move higher at over 75%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where CTS's RSI Indicator exited the oversold zone, 17 of 27 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 63%.
The Momentum Indicator moved above the 0 level on October 27, 2026. You may want to consider a long position or call options on CTS as a result. In 62 of 90 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 69%.
The Moving Average Convergence Divergence (MACD) for CTS just turned positive on October 27, 2026. Looking at past instances where CTS's MACD turned positive, the stock continued to rise in 31 of 45 cases over the following month. The odds of a continued upward trend are 69%.
CTS moved above its 50-day moving average on October 27, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +11.61% 3-day Advance, the price is estimated to grow further. Considering data from situations where CTS advanced for three days, in 210 of 303 cases, the price rose further within the following month. The odds of a continued upward trend are 69%.
The Aroon Indicator entered an Uptrend today. In 154 of 226 cases where CTS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 68%.
Bearish Trend Analysis
The 10-day moving average for CTS crossed bearishly below the 50-day moving average on October 08, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 11 of 19 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 58%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CTS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 62%.
CTS broke above its upper Bollinger Band on October 27, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 27 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 39 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 70, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is 59 (best 1 - 100 worst), indicating steady price growth. CTS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 61 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.952) is normal, around the industry mean (4.491). P/E Ratio (24.573) is within average values for comparable stocks, (5.137). Projected Growth (PEG Ratio) (1.279) is also within normal values, averaging (1.658). Dividend Yield (0.003) settles around the average of (0.019) among similar stocks. P/S Ratio (2.945) is also within normal values, averaging (4.796).
The Tickeron SMR rating for this company is 63 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a manufacturer of electronic components and sensors
Industry ElectronicComponents
Advertisement